FDA’s Hahn Apologizes for Overstating Benefit of COVID-19 Plasma Treatment

On Sunday during a White House press conference, President Trump and several health care regulators announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for convalescent plasma treatments for COVID-19. Since then, FDA Commissioner Stephen Hahn and Health and Human Services Secretary Alex Azar have taken heat for overstating the benefits of the treatment.

Late yesterday, Hahn issued an apology, agreeing that he had overstated the benefits of the treatment.